WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer - WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancer

Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine0 个研究点目标入组 18 人开始时间: 2008年6月26日最近更新: 2023年10月17日

适应症

试验速览

阶段: 1 期
状态: 已完成
发起方
入组人数: 18

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 20years-old 至 75years-old（—）
性别: All

入选标准

未提供

排除标准

•1. There is deep-seated active infection. 2,3 There are severe complications including malignant hypertention, cardiac failure, liver cirrhosis, severe DM, severe lung fiblosis, active interstitial pneumonitis.Patients who have complications that are considered inappropriate for the trial. 4. Dependent on total parenteral nutrition(TPN) 5. There are other malignancies. 6. There are hematopoietic stem cell disorders such as myelodisplastic syndorome(MDS) and myeloproliferative disorders (MPD). 7. Pregnant or lactating woman 8. Past history of severe drug allergy 9. There is severe psychiatric disorder. 10. Responsible doctors judged the patient inappropriate for the trial

研究者

发起方

Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine

相似试验

已完成

1 期

WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreas cancerpancreas cancer

JPRN-UMIN000001187Department of Cancer immunotherapy, Osaka University Medical School18

已完成

1 期

WT1 peptide-based vaccination combined with Gemcitabine for advanced pancreatic and biliary tract cancersadvanced pancreatic and biliary tract cancers

JPRN-UMIN000004081Department of Internal medicine, Division of Gastroenterology and Hepatology, Kashiwa Hospital, Jikei University School of Medicine20

已完成

1 期

PhaseI/II study of WT1 peptide vaccination plus gemcitabine and cisplatin versus gemcitabine and cisplatin in advanced biliary tract canceradvanced biliary tract cancer

JPRN-UMIN000004886ational Cancer Center Hospital106

已完成

2 期

WT1 peptide-based cancer vaccine combined with gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a randomised, multicenter, phase 2 clinical studyPancreatic cancer

JPRN-UMIN000005248Department of Cancer Immunotherapy, Osaka university Graduate school of Medicine150

招募中

1 期

W10TR-GBM2

JPRN-jRCTs061180085eba Tetsuya90